STRATA Skin Sciences, Inc. (NASDAQ:SSKN) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 48,700 shares, a decline of 62.2% from the September 15th total of 128,800 shares. Based on an average daily trading volume, of 74,700 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.2% of the shares of the company are sold short.
Shares of NASDAQ SSKN opened at $1.91 on Thursday. The business has a fifty day simple moving average of $1.62 and a 200 day simple moving average of $1.57. The company has a current ratio of 1.32, a quick ratio of 1.15 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $64.97 million, a price-to-earnings ratio of -21.22 and a beta of 2.45. STRATA Skin Sciences has a one year low of $1.17 and a one year high of $2.84.
STRATA Skin Sciences (NASDAQ:SSKN) last issued its earnings results on Monday, August 16th. The medical device company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.08. The business had revenue of $7.38 million during the quarter, compared to analyst estimates of $6.46 million. STRATA Skin Sciences had a negative return on equity of 19.90% and a negative net margin of 11.88%. On average, research analysts anticipate that STRATA Skin Sciences will post -0.18 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently modified their holdings of SSKN. 22NW LP acquired a new position in STRATA Skin Sciences during the second quarter worth $2,299,000. Cannell Capital LLC raised its stake in STRATA Skin Sciences by 13.3% during the first quarter. Cannell Capital LLC now owns 1,273,401 shares of the medical device company’s stock worth $2,127,000 after acquiring an additional 149,851 shares in the last quarter. Vanguard Group Inc. raised its stake in STRATA Skin Sciences by 8.1% during the second quarter. Vanguard Group Inc. now owns 799,614 shares of the medical device company’s stock worth $1,248,000 after acquiring an additional 60,057 shares in the last quarter. Finally, BlackRock Inc. raised its stake in STRATA Skin Sciences by 5.7% during the first quarter. BlackRock Inc. now owns 124,209 shares of the medical device company’s stock worth $208,000 after acquiring an additional 6,688 shares in the last quarter. Institutional investors and hedge funds own 28.07% of the company’s stock.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.